Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
213.00    -4.00 (-1.84%)
Bid:
213.00
Ask:
214.00
Spread: 1.00 (0.469%)
Market Cap: £588.76m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

AGM Trading Update

17 Apr 2009 07:00

RNS Number : 7204Q
Morgan Crucible Co PLC
17 April 2009
 



AGM Trading Update

At today's AGM, Tim Stevenson, OBE, Morgan Crucible's Chairman, will provide the following update.

Group revenues for the first quarter were £255m compared to £178m in the equivalent period last year with strong first year performance from NP Aerospace and the businesses acquired from Carpenter. Excluding the impact of acquisitions, first quarter revenues were up c.11% year-on-year reflecting the benefits of favourable currency translation. In Q1 we have seen, as anticipated, a continuing downward trend in end-market demand meaning that, on a constant currency basis, organic revenues were down 9% compared to Q1 2008.

Of particular note in the period since our last reported results, is the award from the Ministry of Defence of a contract for the Tactical Support Vehicle (TSV) which we announced in early April. This will generate c.£30m of new revenues for NP Aerospace in the latter part of this year and the first half of 2010. 

The refinancing of the Group's banking facilities which mature in March 2010 has progressed well and we are now in the final stages of documentation for the new facility.

Going forward, the ongoing uncertainty in the global economy clearly makes it much more difficult to forecast demand accurately. However, to ensure that we are well prepared for any further deterioration in end market conditions, we are continuing to take decisive action to reduce our operating cost base. Group overall headcount at the end of Q1, excluding acquisitions, has been reduced by over 1,000 people (c.10%) worldwide from its levels of last summer and we stand ready to take further mitigating actions as required.

Our next announcement to shareholders will be our Interim Management Statement in mid May when we will update further on the Group's trading and prospects.

Enquiries:

The Morgan Crucible Company plc  01753 837000

Mark Robertshaw, Chief Executive

Kevin Dangerfield, Chief Financial Officer 

Finsbury Group 020 7251 3801

Mike Smith

Clare Strange

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBRGDSGGBGGCL
Date   Source Headline
28th Apr 20209:15 amRNSDisclosure of Rights Attached to Listed Securities
9th Apr 20201:33 pmRNSNotice of AGM
2nd Apr 20205:01 pmRNSDirector/PDMR Shareholding
1st Apr 20201:04 pmRNSAnnual Financial Report
31st Mar 20207:00 amRNSCOVID-19 Update
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
19th Mar 202012:22 pmRNSDirector/PDMR Shareholding
12th Mar 202010:14 amRNSDirector/PDMR Shareholding
11th Mar 202010:57 amRNSDirector/PDMR Shareholding
3rd Mar 20205:29 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSFull-year Results
16th Dec 20199:10 amRNSBlock listing Interim Review
2nd Dec 20199:10 amRNSDirector Declaration
18th Nov 201911:00 amRNSDirector/PDMR Shareholding
13th Nov 20199:48 amRNSDirector/PDMR Shareholding
12th Nov 201912:23 pmRNSDirector/PDMR Shareholding
11th Nov 20194:04 pmRNSDirector/PDMR Shareholding
11th Nov 20192:44 pmRNSDirector/PDMR Shareholding
8th Nov 20197:00 amRNSTrading Update
23rd Oct 20191:56 pmRNSHolding(s) in Company
23rd Oct 20191:54 pmRNSHolding(s) in Company
23rd Sep 201912:03 pmRNSDirector/PDMR Shareholding
3rd Sep 20192:21 pmRNSHolding(s) in Company
25th Jul 20197:00 amRNSHalf-year Report
17th Jun 20198:06 amRNSBlock listing Interim Review
7th Jun 20199:38 amRNSHolding(s) in Company
24th May 20191:08 pmRNSDirector/PDMR Shareholding
10th May 201912:14 pmRNSResult of AGM
10th May 20197:00 amRNSTrading Update
7th May 20194:36 pmRNSDirectorate Change
8th Apr 20195:29 pmRNSDirector/PDMR Shareholding
3rd Apr 201911:22 amRNSAnnual Financial Report
19th Mar 20199:47 amRNSDirector/PDMR Shareholding
19th Mar 20199:44 amRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFinal Results
17th Dec 201810:51 amRNSBlock listing Interim Review
21st Nov 20182:36 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSDivestment of Composites and Defence Systems
9th Nov 20187:00 amRNSTrading Update
22nd Oct 20185:17 pmRNSHolding(s) in Company
28th Sep 20188:17 amRNSCompletion of Bank Refinancing
6th Aug 20189:24 amRNSDirector/PDMR Shareholding
1st Aug 20188:54 amRNSDirector/PDMR Shareholding
26th Jul 20187:00 amRNSHalf-year results
2nd Jul 20182:37 pmRNS2017 Environmental, Health and Safety Report
2nd Jul 20187:00 amRNSDirectorate Change
15th Jun 20189:00 amRNSBlock listing Interim Review
11th May 20181:32 pmRNSResult of AGM
1st May 20182:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.